Question explored with the scientific record
Cold peptides
"Cold peptides" is not a defined product, so there is nothing here to judge as safe or effective for you.
The term is ambiguous. It could mean peptides studied for cold adaptation, peptides from cold environments, or peptides marketed for colds. The retrieved records cover only the first two, and none tested a consumer product in people.
The closest match is MOTS-c, a mitochondrial peptide. In mice, injected MOTS-c helped them hold body temperature during acute cold exposure and reduced cold-induced liver fat [1]. That is a mouse study with 8 animals per group, not a human trial [1]. It says nothing about a supplement you can buy.
The other "cold" records are unrelated to human health claims. One catalogs antimicrobial peptides from deep-sea cold seeps, synthesized and tested against microbes in the lab [4]. Another describes a bacterial "cold shock" protein that protects ribosomes [3]. Neither is a human intervention.
| What was studied | Species | Human relevance |
|---|---|---|
| MOTS-c for cold adaptation | Mice [1] | None established |
| Deep-sea antimicrobial peptides | Lab microbes [4] | None established |
| Cold shock ribosomal protein | Bacteria [3] | None |
No record here tested any peptide for preventing or treating the common cold in people. The vitamin D record [2] is about respiratory infection, not peptides, so it does not answer this either.
My call: there is no human evidence that any "cold peptide" product does anything for you, and the mouse data on MOTS-c does not transfer to a supplement. Confidence: moderate that the marketed category is unproven; the retrieval is too thin to say more.
Sources used 4
-
Mitochondrial-Derived Peptide MOTS-c Increases Adipose Thermogenic Activation to Promote Cold Adaptation
MOTS-c administration promotes cold adaptation in mice by increasing brown and beige adipose thermogenesis through ERK signaling, reducing acute cold-induced hyperlipidemia and hepatic lipid deposition.
DOI: 10.3390/ijms20102456 -
Vitamin D, innate immunity and upper respiratory tract infection
This narrative review concludes that vitamin D regulates upper-airway innate immunity by inducing cathelicidin and defensins, that low vitamin D is associated with increased respiratory infection, and that supplementation studies suggest benefit, though optimal levels and dosing…
DOI: 10.1017/s0022215109992684 -
Cryo-EM reveals multiple mechanisms of ribosome inhibition by doxycycline
Using high-resolution cryo-EM to compare doxycycline binding in Coxiella burnetii and Escherichia coli ribosomes, the study reveals unexpected dual-subunit binding of doxycycline, a novel Coxiellaceae ribosomal peptide (CLaSP) and an HPF-like hibernation factor with a cold shock…
DOI: 10.1101/2025.11.08.686982 -
A global deep-sea small protein atlas reveals a reservoir of noncanonical antimicrobial peptides
A global metagenomic and experimental study constructs the Deep-Sea Small Protein Atlas across five deep-sea biomes, uncovering 88.7 million smORFs and 5.47 million predicted antimicrobial peptides (c_AMPs), synthesizing 131 representative peptides that broadly kill microbes wit…
DOI: 10.64898/2025.12.15.694180